In the present study, the effects of matrine treatment on multiple breast cancer cell lines, including ER-positive MCF7 cells, HER2-positive BT-474 cells and the highly metastatic MDA-MB-231 cell line, were determined. This evidence concerns the gene ERBB2 and breast carcinoma.